Jones Financial Companies’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.13M Buy
11,186
+2,171
+24% +$449K ﹤0.01% 1400
2025
Q4
$1.86M Buy
9,015
+367
+4% +$73.3K ﹤0.01% 982
2025
Q3
$1.52M Buy
8,648
+373
+5% +$63.5K ﹤0.01% 965
2025
Q2
$1.33M Buy
8,275
+427
+5% +$68K ﹤0.01% 898
2025
Q1
$1.29M Buy
7,848
+2,443
+45% +$424K ﹤0.01% 774
2024
Q4
$898K Buy
5,405
+2,026
+60% +$346K ﹤0.01% 779
2024
Q3
$578K Buy
3,379
+571
+20% +$94.5K ﹤0.01% 773
2024
Q2
$432K Buy
2,808
+689
+33% +$103K ﹤0.01% 601
2024
Q1
$326K Buy
2,119
+846
+66% +$129K ﹤0.01% 389
2023
Q4
$201K Buy
+1,273
New +$183K ﹤0.01% 327
2023
Q1
Sell
-5
Closed -$1K 638
2022
Q4
$1K Buy
+5
New +$738 ﹤0.01% 665

Other funds holding FBT

Jones Financial Companies's FBT Position: Q1 2026 in Review

Jones Financial Companies increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 24% in Q1 2026, buying an estimated $449K and bringing the position to 11,186 shares worth $2.13M. The position accounts for ﹤0.01% of the portfolio, ranked #1400.

Jones Financial Companies first reported a position in FBT in Q4 2022 and has held it in 11 quarters since. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

  • Jones Financial Companies held 11,186 shares of First Trust NYSE Arca Biotechnology Index Fund worth $2.13M as of Q1 2026.
  • Jones Financial Companies bought 2,171 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2026, an estimated $449K.
  • First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #1400 holding.
  • Jones Financial Companies first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2022 and has held it in 11 quarters since.
  • 307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.